博客

格林-巴利综合征

格林-巴利综合征与重症肌无力

Man with Guillain-Barre Syndrome holding hand

格林-巴利综合征 (GBS) and 重症肌无力 (MG) are neurological autoimmune disorders that occur when the body’s immune system starts attacking healthy cells, such as nerves and muscles. GBS and MG both are actually severe but rare conditions that can cause significant physical impairments and even lead to life-threatening complications if left untreated. Although both disease states share some similarities, such as muscle weakness and fatigue, the underlying mechanisms, affected population, symptoms, onset, progression, and treatment approaches differ significantly. 

与专家交谈

关于共付额援助
(877) 778-0318

In this article, we will explain the key differences between GBS and MG, and the available treatments to manage the symptoms of these neurological disorders.

Guillain-Barré Syndrome vs. Myasthenia Gravis: Key Differences

Underlying Mechanism

Guillain-barré syndrome is caused by the immune system attacking the peripheral nerves, which are located outside the brain and control movement and sensation. The immune system produces antibodies that mistakenly target the myelin sheath (a protective covering around the nerves) or the nerve fibers themselves, leading to nerve damage and inflammation. This damage disrupts the transmission of signals from the brain to the muscles and results in muscle weakness and paralysis.

Myasthenia gravis is also caused by an immune system attack. Unlike GBS, in MG, the immune system attacks the neuromuscular junctions which are points where nerve cells connect with the muscles. Typically, nerve cells release 乙酰胆碱 (a neurotransmitter) that attaches to its receptor on muscle fibers. The attachment of the acetylcholine to its receptors causes the muscle to contract and produce movement. However, in people with MG, the immune system produces antibodies that destroy or block these receptors on muscle fibers and prevent them from receiving nerve signals (acetylcholine). This leads to muscle weakness and fatigue due to impaired muscle contractions. 

Symptoms of Guillain-Barré Syndrome vs. Myasthenia Gravis

The symptoms of GBS and MG differ significantly. The symptoms of GBS usually start with tingling and numbness in the feet and legs that gradually spread to the upper body and arms. Muscle weakness can progress rapidly and sometimes even affect respiratory muscles, leading to paralysis, which can be life-threatening. Other early and severe symptoms may include tingling or numbness in the extremities, vision problems, loss of reflexes, and difficulty in speaking, swallowing, and breathing. These symptoms begin quickly and become worse within hours or days. 

Conversely, MG symptoms can vary widely depending on the severity and location of muscle weakness. MG typically presents with fluctuating muscle weakness that affects specific muscles that can be controlled voluntarily. The muscle groups which are severely affected by MG include:

  • Eye and eyelid muscles that control eye movement. Approximately 50% of people who suffer from myasthenia gravis experience early symptoms of eye problems such as double vision & one or both eyelids drooping (called ptosis). 
  • Facial and throat muscles that control facial expressions. Around 15% of individuals with myasthenia gravis experience initial symptoms like changes in facial expressions, double vision, impaired speaking or slurred speech, and difficulty chewing and swallowing. 
  • Neck and limb muscles usually control the movement of arms, legs, neck, fingers, and hands.

In some cases, the symptoms of MG can be life-threatening, particularly if they affect the muscles that control breathing. Moreover, the weakness in MG tends to worsen with activity and improve with rest.

Susceptible Population

GBS can affect anyone, regardless of age or gender, but it is more common in adults and the geriatric population. On the other hand, myasthenia gravis (MG) can affect people of any gender, race, or ethnicity. It usually affects adult women under the age of 40 and men over the age of 60. 

Onset and Progression

The onset and progression of Guillain-barré syndrome vs. myasthenia gravis are also different. GBS often has a sudden and rapid onset, with 症状 reaching their peak within 2 to 3 weeks. After that, it begins to improve. The recovery process takes about several months or even years, depending on the severity of the illness. Some people may experience ongoing symptoms such as weakness, fatigue, and difficulty with coordination even after recovery. 

In contrast, MG may have a more gradual onset, with 症状 appearing over a period of weeks or months. The progression of MG can be unpredictable and varies from person to person. Some people may experience mild symptoms that are well-controlled with medication, while others may have severe symptoms that significantly impact their quality of life. In some cases, the symptoms may go into remission for a period of time, only to return later. However, with proper treatment, most people with MG can manage their symptoms and lead normal lives.

获得共付额援助

治疗信息 | 获得事先授权
安排咨询

Factors That Trigger GBS and MG

The exact cause of GBS is still unknown, but researchers believe it is triggered by an infection or other illnesses. In many cases, GBS develops a few days or weeks after a respiratory or gastrointestinal infection. 

Other factors that can trigger the onset of GBS include;

  • Zika virus and COVID-19
  • Vaccination, surgery, or trauma

In the case of MG, the exact cause is still unknown, but it is believed to be related to or triggered by various environmental and genetic factors. 

Treatment Options for Guillain-Barré Syndrome vs. Myasthenia Gravis

Although there is no cure for GBS and MG, effective treatment strategies can help to improve the symptoms and speed up the recovery time in patients with these conditions. Like the above factors, the treatment approaches for GBS and MG are different. 

GBS is typically treated with immunoglobulin therapy or plasma exchange. 

  • IVIG for Guillain-barre syndrome静脉注射免疫球蛋白治疗 involves infusing high-dose antibodies into the bloodstream of the patients. This therapy helps to suppress the immune system and reduce inflammation. 
  • 血浆置换 involves replacing patients’ blood plasma with donor plasma or a substitute. This helps to remove the antibodies that are attacking the nerves.

In the case of MG, it is typically treated with medications, surgery, and therapies. 

  • 药物 such as acetylcholinesterase inhibitors or immunosuppressive drugs are used to enhance nerve signaling and reduce the immune system’s attack on the neuromuscular junction. 
  • 血浆置换 and intravenous immunoglobulin therapies may benefit MG patients as these therapies remove the antibodies from the blood. 
  • 胸腺切除术, a surgical procedure of problematic thymus gland removal, plays a role in rebalancing the immune system and reducing the symptoms. 

In conclusion, Guillain-barré syndrome and myasthenia gravis are both neurological autoimmune disorders and share some similarities in their symptoms and manifestations. However, both diseases differ in several ways such as the underlying mechanisms, causes, patterns of muscle weakness, and treatment approaches. Understanding the difference between GBS and MG and early diagnosis can help improve outcomes for those affected by these conditions.

参考:

  1. Leonhard, S. E., Mandarakas, M. R., De Assis Aquino Gondim, F., Bateman, K., Ferreira, M. E. C., Cornblath, D. R., Van Doorn, P. A., Dourado, M. E., Hughes, R. a. C., Islam, B., Kusunoki, S., Pardo, C. A., Reisin, R., Sejvar, J. J., Shahrizaila, N., Soares, C. N., Umapathi, T., Wang, Y., Yiu, E. M., . . . Jacobs, B. (2019). Diagnosis and management of Guillain–Barré syndrome in ten steps. Nature Reviews Neurology, 15(11), 671–683. https://doi.org/10.1038/s41582-019-0250-9
  2. Dresser, L., Wlodarski, R., Rezania, K., & Soliven, B. (2021). Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations. Journal of Clinical Medicine, 10(11), 2235. https://doi.org/10.3390/jcm10112235
  3. Nguyen, T. P. (2023, February 7). Guillain Barre Syndrome. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK532254/#:~:text=Guillain%2DBarr%C3%A9%20syndrome%20(GBS),that%20can%20progress%20to%20paralysis.
  4. Yuki, N., & Hartung, H. (2012). Guillain–Barré Syndrome. The New England Journal of Medicine, 366(24), 2294–2304. https://doi.org/10.1056/nejmra1114525
  5. Gilhus, N. E., Tzartos, S. J., Evoli, A., Palace, J., Burns, T. M., & Verschuuren, J. J. (2019). Myasthenia gravis. Nature Reviews Disease Primers, 5(1). https://doi.org/10.1038/s41572-019-0079-y
  6. Freshimona, R., Wijaya, A., Aryatama, Djojoatmodjo, S., Liman, J., & Sari, P. (2021). P-PN018. The co-occurrence of myasthenia gravis and Guillain-Barré Syndrome: A case report. 临床神经生理学, 132(8), e111. https://doi.org/10.1016/j.clinph.2021.02.267
此信息不能替代医疗建议或治疗。在开始任何新的治疗之前,请咨询您的医生或医疗保健提供者,了解您的医疗状况。AmeriPharma® Specialty Care 对所提供的信息或由此做出的任何诊断或治疗不承担任何责任,也不对其内容的可靠性负责。AmeriPharma® Specialty Care 并非运营此处列出的所有网站/组织,也不对其内容的可用性或可靠性负责。这些列表并不暗示或构成 AmeriPharma® Specialty Care 的认可、赞助或推荐。本网页可能包含对品牌处方药的引用,这些处方药是与 AmeriPharma® Specialty Care 无关的制药商的商标或注册商标。
Portrait of Saba R., a pharmacist sharing her experience with specialty treatment.
医学审核人 Saba Rassouli 博士,药学博士

Saba Rassouli 博士,药学博士,在伊朗出生长大。她于2022年以优异成绩毕业于马歇尔·B·凯彻姆大学,获得药学学位。工作中最让她感到满足的部分是能够像家人一样照顾每一位患者,并听到他们对AmeriPharma提供的服务感到满意和高兴。闲暇时,她喜欢散步、读书,以及品尝不同的餐厅和美食。

联系我们

使用下方符合 HIPAA 标准的表格申请续药。如果您对药物或用药方法有任何疑问,请访问“联系我们”页面或致电 (877) 778-0318.

HIPAA Compliant

提交即表示您同意 AmeriPharma 的 使用条款, 隐私政策, 和 隐私惯例通知

zh_CNChinese